Atlas Trials

Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer

Clinical trial NCT01320683 · TERMINATED

Trial details

NCT number
NCT01320683
Sponsor
City of Hope Medical Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Liver MetastasesRecurrent Colon CancerRecurrent Rectal CancerStage IVA Colon CancerStage IVA Rectal CancerStage IVB Colon CancerStage IVB Rectal Cancer
Start date
2011-03-01
Primary completion
2014-12-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.